 The primary objective of this study is to evaluate the safety of Autologous Muscle Derived Cells for Gastro-Intestinal Repair AMDC-GIR during the 12 months following treatment of tongue dysphagia in male and female patients who have undergone surgery andor chemo- andor radiotherapy for squamous cell cancer of the oropharynx. 